IPO - Rani Therapeutics Holdings, Inc.

Form Type: S-3

Filing Date: 2025-07-03

Corporate Action: Ipo

Type: New

Accession Number: 000119312525155461

Filing Summary: Rani Therapeutics Holdings, Inc., a clinical stage biotherapeutics company, filed a registration statement under the Securities Act of 1933 on July 3, 2025, to register the resale of up to 13,160,172 shares of Class A common stock. These shares are issuable upon exercise of the Series D common stock warrant, which was previously issued in exchange for the cash exercise of existing warrants at a reduced price of $0.65 per share. The filing indicates that the company is not selling the shares itself and will not receive proceeds from the resale, except from the exercise of the warrant. The Class A common stock is currently listed on The Nasdaq Global Market under the symbol 'RANI.' The document emphasizes the risks associated with investing in the shares, as well as providing insights into the company’s development stage efforts in advancing its proprietary drug delivery technology, notably the RaniPill capsule designed for oral drug administration. The registration emphasizes the company’s focus on entering clinical trials and potential commercialization plans in the future, highlighting their fundraising strategy and partnerships with other biopharmaceutical companies.